CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Generally, for people with non Hodgkin lymphoma in England and Wales: 1  about 80 out of every 100 people (about 80%) survive their cancer for 1 year or more after they are diagnosed. 2  around 70 out of every 100 people (around 70%) survive their cancer for 5 years or more after diagnosis.